EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial

Hong-Kyun Park, Jong-Ho Park, Hee-Kwon Park, Kyusik Kang, Keun-Hwa Jung, Beom Joon Kim, Jin-Man Jung, Young Seo Kim, Yong-Seok Lee, Hyo Suk Nam, Yeonju Yu, Juneyoung Lee und 1 weitere

Journal of Stroke · 31.05.2025 · 27 (2) · 275-278

DOI: 10.5853/jos.2024.05015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Stroke, erschienen am 31.05.2025. Verfasst von Hong-Kyun Park und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Samjin Pharm.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Neurology, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
  • Department of Neurology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
  • Department of Neurology, Inha University Hospital, Inha University School of Medicine, Incheon, Korea.
  • Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
  • Department of Neurology, Seoul National University Hospital, Seoul, Korea.
  • Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.

Förderung

  • Samjin Pharm

Zitieren

APA

Park, H. K., Park, J. H., Park, H. K., Kang, K., Jung, K. H., Kim, B. J., Jung, J. M., Kim, Y. S., Lee, Y. S., Nam, H. S., Yu, Y., Lee, J., & Hong, K. S. (2025). Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial. Journal of Stroke, 27(2), 275-278. https://doi.org/10.5853/jos.2024.05015

Vancouver

Park HK, Park JH, Park HK, Kang K, Jung KH, Kim BJ, et al. Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial. Journal of Stroke. 2025;27(2):275-278. doi:10.5853/jos.2024.05015

BibTeX
@article{Park2025,
  author = {Park, Hong-Kyun and Park, Jong-Ho and Park, Hee-Kwon and Kang, Kyusik and Jung, Keun-Hwa and Kim, Beom Joon and Jung, Jin-Man and Kim, Young Seo and Lee, Yong-Seok and Nam, Hyo Suk and Yu, Yeonju and Lee, Juneyoung and Hong, Keun-Sik},
  title = {Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial},
  journal = {Journal of Stroke},
  year = {2025},
  volume = {27},
  number = {2},
  pages = {275--278},
  doi = {10.5853/jos.2024.05015}
}
Kostenlos starten →